Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2014 May;9(5):831-6.
doi: 10.2215/CJN.02480314. Epub 2014 Apr 10.

Novel treatments of autosomal dominant polycystic kidney disease

Affiliations
Editorial

Novel treatments of autosomal dominant polycystic kidney disease

Rex L Mahnensmith. Clin J Am Soc Nephrol. 2014 May.
No abstract available

Keywords: ADPKD; mTOR inhibitors; somatostatin analogs; statins; vasopressin antagonists.

PubMed Disclaimer

Comment on

  • 881–888
  • 889–896

References

    1. Torres VE, Harris PC, Pirson Y: Autosomal dominant polycystic kidney disease. Lancet 369: 1287–1301, 2007 - PubMed
    1. Grantham JJ: Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med 359: 1477–1485, 2008 - PubMed
    1. Torres VE: Treatment strategies and clinical trial design in ADPKD. Adv Chronic Kidney Dis 17: 190–204, 2010 - PMC - PubMed
    1. Wang X, Wu Y, Ward CJ, Harris PC, Torres VE: Vasopressin directly regulates cyst growth in polycystic kidney disease. J Am Soc Nephrol 19: 102–108, 2008 - PMC - PubMed
    1. Pei Y: Molecular genetics of autosomal dominant polycystic kidney disease. Clin Invest Med 26: 252–258, 2003 - PubMed

Publication types

MeSH terms

Substances